Notice2023-05984
Menopause and Optimizing Midlife Health of Women
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 23, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
This symposium is sponsored by the NIH Office of Research on Women's Health (ORWH), the title of this year's symposium is "Menopause and Optimizing Midlife Health of Women." The symposium will discuss menopausal transition, accumulation of morbidity after menopause, menopause in special populations, social determinants of health, menopausal hormonal therapy, and interventions to promote healthy aging.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 56 (Thursday, March 23, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17586-17587]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Menopause and Optimizing Midlife Health of Women
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This symposium is sponsored by the NIH Office of Research on
Women's Health (ORWH), the title of this year's symposium is
``Menopause and Optimizing Midlife Health of Women.'' The symposium
will discuss menopausal transition, accumulation of morbidity after
menopause, menopause in special populations, social determinants of
health, menopausal hormonal therapy, and interventions to promote
healthy aging.
DATES: The meeting will be held on May 16, 2023, from 10 a.m. to 5 p.m.
ADDRESSES: The meeting will be virtual. Registration is available at
<a href="https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA">https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA</a>. The
meeting is viewable on NIH Videocast at <a href="https://videocast.nih.gov/watch=49307">https://videocast.nih.gov/watch=49307</a>; no registration required.
FOR FURTHER INFORMATION CONTACT: For information concerning this
meeting, see the ORWH website, <a href="https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium">https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium</a>, or contact Dr. Sarah Temkin,
Associate Director for Clinical Research, Office of Research on Women's
Health, 6707 Democracy Boulevard, Suite 400, Bethesda, MD 20817,
telephone: 301-402-1770; email: <a href="/cdn-cgi/l/email-protection#f5869487949ddb8190989e9c9bb59b9c9ddb929a83"><span class="__cf_email__" data-cfemail="2053415241480e54454d4b494e604e49480e474f56">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This Notice is in accordance with 42 U.S.C.
287d, of the Public Health Service Act, as amended. The 7th Annual
Vivian W. Pinn Symposium honors the first full-
[[Page 17587]]
time director of ORWH, Dr. Vivian Pinn, and is held during National
Women's Health Week. This event serves as a critical forum for experts
across sectors to communicate and collaborate for the advancement of
women's health.
Providing the keynote address, ``Menopausal Hormone Therapy: 30
Years of Lessons from the Women's Health Initiative,'' is JoAnn Manson,
M.D., Professor of Medicine at Harvard Medical School and Chief of the
Division of Preventive Medicine, Department of Medicine at Brigham and
Women's Hospital. A patient advocacy panel will discuss the patient
perspective of menopause.
The objectives of the symposium are to:
<bullet> Familiarize attendees with state of the science related to
our understanding of risk factors and mechanisms that lead to
reproductive aging.
<bullet> Understand women's unique morbidity and multimorbidity
burden to identify points of intervention.
<bullet> Identify the needs of populations at risk for iatrogenic
menopause (patients with germline inherited cancer risk) and early or
complex menopausal symptoms (patients living with HIV, chronic
conditions, and cancer).
<bullet> Identify priorities to address unmet environmental and
other exposures as it relates to menopausal transition and symptoms in
diverse populations of women.
<bullet> Understand current recommendations on menopausal hormone
therapy prescribing including when to start and stop, and formulations
and durations of use.
Interested individuals can register at: <a href="https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA">https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA</a>. More information about the
speakers and agenda can be found at <a href="https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium">https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium</a>. This event is free.
Dated: March 17, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2023-05984 Filed 3-22-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 23, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.